BIRC5 and familial pancreatic carcinoma: In a study using a pancreatic cancer cell line, Asanuma et al reported that survivin may be a radioresistant factor [12], and Kato et al suggested that survivin expression may be a predictive marker for chemotherapy as well as prognostic marker in esophageal cancer in their previous study [9].